US Bancorp DE trimmed its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 14.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 62,455 shares of the company's stock after selling 10,127 shares during the quarter. US Bancorp DE's holdings in Ryan Specialty were worth $4,007,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. State Street Corp boosted its holdings in shares of Ryan Specialty by 1.5% during the third quarter. State Street Corp now owns 3,273,093 shares of the company's stock worth $217,301,000 after purchasing an additional 49,198 shares during the period. Janus Henderson Group PLC boosted its holdings in shares of Ryan Specialty by 0.4% during the third quarter. Janus Henderson Group PLC now owns 3,148,916 shares of the company's stock worth $209,058,000 after purchasing an additional 13,986 shares during the period. Principal Financial Group Inc. boosted its holdings in shares of Ryan Specialty by 115.2% during the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock worth $117,619,000 after purchasing an additional 981,505 shares during the period. Barclays PLC boosted its holdings in shares of Ryan Specialty by 1.1% during the third quarter. Barclays PLC now owns 1,641,743 shares of the company's stock worth $108,994,000 after purchasing an additional 17,267 shares during the period. Finally, Eagle Asset Management Inc. boosted its holdings in shares of Ryan Specialty by 32.1% during the third quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company's stock worth $98,555,000 after purchasing an additional 335,180 shares during the period. 84.82% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several analysts recently commented on the stock. UBS Group raised their price target on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a report on Wednesday, February 26th. Wells Fargo & Company raised their price target on shares of Ryan Specialty from $64.00 to $69.00 and gave the stock an "equal weight" rating in a report on Friday, February 21st. Royal Bank of Canada cut their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday, February 21st. Morgan Stanley started coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They set an "overweight" rating and a $90.00 price objective on the stock. Finally, Keefe, Bruyette & Woods cut their price objective on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating on the stock in a research report on Friday, February 21st. One analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $75.27.
Check Out Our Latest Stock Report on RYAN
Ryan Specialty Stock Performance
Shares of NYSE:RYAN traded up $0.09 during trading on Friday, reaching $69.31. The stock had a trading volume of 763,446 shares, compared to its average volume of 988,549. Ryan Specialty Holdings, Inc. has a 52 week low of $48.48 and a 52 week high of $75.97. The firm has a market capitalization of $18.15 billion, a price-to-earnings ratio of 100.45, a P/E/G ratio of 1.19 and a beta of 0.71. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock has a fifty day simple moving average of $66.57 and a two-hundred day simple moving average of $67.59.
Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The firm had revenue of $663.53 million during the quarter, compared to the consensus estimate of $658.80 million. As a group, analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.
Ryan Specialty Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th will be paid a $0.12 dividend. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. The ex-dividend date is Tuesday, March 4th. This represents a $0.48 annualized dividend and a dividend yield of 0.69%. Ryan Specialty's dividend payout ratio (DPR) is presently 69.57%.
Insider Transactions at Ryan Specialty
In other news, Director Nicholas Dominic Cortezi sold 10,485 shares of the firm's stock in a transaction on Thursday, January 23rd. The shares were sold at an average price of $65.12, for a total value of $682,783.20. Following the sale, the director now owns 11,109 shares in the company, valued at approximately $723,418.08. This trade represents a 48.56 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Over the last quarter, insiders have sold 316,451 shares of company stock worth $20,907,793. Insiders own 11.10% of the company's stock.
Ryan Specialty Company Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Stories

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report